Cargando…

Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors

[Image: see text] Finding antivirals for SARS-CoV-2 is still a major challenge, and many computational and experimental approaches have been employed to find a solution to this problem. While the global vaccination campaigns are the primary driver of controlling the current pandemic, orally bioavail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puhl, Ana C., Mottin, Melina, Sacramento, Carolina Q., Tavella, Tatyana Almeida, Dias, Gabriel Gonçalves, Fintelman-Rodrigues, Natalia, Temerozo, Jairo R., Dias, Suelen S. G., Ramos, Paulo Ricardo Pimenta da Silva, Merten, Eric M., Pearce, Kenneth H., Costa, Fabio Trindade Maranhão, Premkumar, Lakshmanane, Souza, Thiago Moreno L., Andrade, Carolina Horta, Ekins, Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380819/ https://www.ncbi.nlm.nih.gov/pubmed/35983371 http://dx.doi.org/10.1021/acsomega.2c01707

Ejemplares similares

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
por: Puhl, Ana C., et al.
Publicado: (2021)

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
por: Puhl, Ana C., et al.
Publicado: (2020)

Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation
por: Soares, Vinicius Cardoso, et al.
Publicado: (2023)

HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion
por: Mesquita, Milene, et al.
Publicado: (2014)

Fluorine Atoms on C(6)H(5)-Corrole Affect the Interaction with M(pro) and PL(pro) Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
por: Lechuga, Guilherme C., et al.
Publicado: (2021)

Déjà vu: Stimulating open drug discovery for SARS-CoV-2
por: Ekins, Sean, et al.
Publicado: (2020)

Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
por: Fintelman-Rodrigues, Natalia, et al.
Publicado: (2020)

High Throughput and Computational Repurposing for Neglected Diseases
por: Hernandez, Helen W., et al.
Publicado: (2018)

SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
por: Ferreira, André C., et al.
Publicado: (2021)

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
por: Ferreira, André C., et al.
Publicado: (2021)

Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
por: Sacramento, Carolina Q., et al.
Publicado: (2022)

Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2020)

Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
por: Chaves Filho, Adriano José Maia, et al.
Publicado: (2021)

Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
por: Dias, Suelen Silva Gomes, et al.
Publicado: (2020)

Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
por: Wang, Xuanting, et al.
Publicado: (2021)

Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
por: Wang, Xuanting, et al.
Publicado: (2022)

OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug Discovery
por: Ekins, Sean, et al.
Publicado: (2016)

The Chemokine CCL5 Inhibits the Replication of Influenza A Virus Through SAMHD1 Modulation
por: Silva, Thauane, et al.
Publicado: (2021)

Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
por: Hottz, Eugenio D., et al.
Publicado: (2022)

The A–Z of Zika drug discovery
por: Mottin, Melina, et al.
Publicado: (2018)

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
por: Aragão, Luiz Guilherme H. S., et al.
Publicado: (2021)

Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating
por: Salerno, José Alexandre, et al.
Publicado: (2021)

Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
por: Teixeira, Lívia, et al.
Publicado: (2022)

Non-permissive SARS-CoV-2 infection in human neurospheres
por: Pedrosa, Carolina da S. G., et al.
Publicado: (2021)

Non-permissive SARS-CoV-2 infection in human neurospheres
por: Pedrosa, Carolina da S.G., et al.
Publicado: (2021)

QSAR-Based Virtual Screening of Natural Products Database for Identification of Potent Antimalarial Hits
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2021)

Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M(pro), Impairing Variants Replication In Vitro and In Vivo
por: Chaves, Otávio Augusto, et al.
Publicado: (2021)

Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice
por: Puhl, Ana C., et al.
Publicado: (2021)

Neuroendocrine Control of Macrophage Development and Function
por: Jurberg, Arnon Dias, et al.
Publicado: (2018)

Detection of the Influenza A(H1N1)pdm09 Virus Carrying the K-15E, P83S and Q293H Mutations in Patients Who Have Undergone Bone Marrow Transplant
por: Mesquita, Milene, et al.
Publicado: (2014)

Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
por: Puhl, Ana C., et al.
Publicado: (2022)

Benzo[f]indole-4,9-dione Derivatives Effectively Inhibit the Growth of Triple-Negative Breast Cancer
por: Guerra, Fabiana Sélos, et al.
Publicado: (2021)

Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
por: Temerozo, Jairo R., et al.
Publicado: (2022)

Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
por: Souza, Thiago Moreno L., et al.
Publicado: (2023)

Machine Learning for Discovery of New ADORA Modulators
por: Puhl, Ana C., et al.
Publicado: (2022)

A diarylamine derived from anthranilic acid inhibits ZIKV replication
por: Silva, Suely, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9s6kk4t5hoc2l282ufiuokl52l